Report Overview

The China Interstitial Cystitis Therapeutics market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Interstitial Cystitis is a chronic, painful inflammatory condition of the bladder wall characterized by pressure and pain above the pubic area along with increased frequency of urination. Chinas interstitial cystitis market is growing due to the increase in prevalence of the disease. The disease prevalence in China is 100 people per 100000, increased prevalence is associated with the female gender in China (701.08 million females in 2020).



Market Drivers

China is the growing market for Interstitial Cystitis disease due to a greater number of Female populations (701.08 million females in 2020) and increase in prevalence in China (100 people per 100000). An improved understanding of the pathophysiology of the condition among physicians has led to the increasing amount of diagnosis. Evidence based treatment and evolving epidemiology leads to increase in market growth of interstitial cystitis.

There are some restraining factors for growth of the interstitial cystitis therapeutics market in China such as complex diagnostic procedures leading to misdiagnosis, underdiagnosis.